Researchers enhance CAR-T cells to target solid tumors

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 66 sec. here
  • 27 min. at publisher
  • 📊 Quality Score:
  • News: 114%
  • Publisher: 71%

Antibody News

Antigen,Blood,Blood Vessels

Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors-;an advance that could transform cancer treatment.

May 8 2024Albert Einstein College of Medicine Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors-;an advance that could transform cancer treatment. The promising findings, reported today in Science Advances, involve CAR-T cell therapy, which supercharges the immune system to identify and attack cancer cells.

CAR-T cell therapy, short for chimeric antigen receptor -T cell therapy, is a marvel of genetic engineering that transforms T cells into cancer-seeking missiles programmed to attack on contact. The therapy involves extracting the patient's own T cells and equipping them with a single gene that codes for several different proteins. The genetically modified T cells are allowed to multiply and are then infused back into the patient.

Five CAR-Ts confront three types of cancer All five CAR-T therapies developed by the Zang team used the same novel targeting protein: a monoclonal antibody that binds to B7-H3, a cancer-cell antigen widely expressed on most solid tumors and their blood vessels. Dr. Zang had previously helped to discover that B7-H3 allows tumors to evade immune attack by interfering with T cells.

"Factors such as low-oxygen levels and immune checkpoints inside solid tumors make for a hostile microenvironment that can strongly suppress immune attack by T cells-;which also have trouble penetrating solid tumors' dense connective tissue network," Dr. Zang said. "It seemed possible that using TMIGD2 as a costimulatory protein could give CAR-T cells the activation boost they need to reach cancer cells and persist within solid tumors.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Belfast mum diagnosed with cancer after noticing 'odd-looking spot'Lyn's skin cancer was detected by the Action Cancer's skin cancer detection service
Source: BelfastLive - 🏆 16. / 77 Read more »

Researchers stimulate gene that enhances CAR T-cell treatments for solid tumorsResearchers at Peter Mac have overcome a major barrier that could see a revolutionary immunotherapy treatment becoming successful on patients with solid cancer types.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers identify what drives PARP inhibitor resistance in advanced breast cancerResearchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict who's more likely to respond to these drugs, and could lead to more effective ways to treat the disease.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers use foundation models to discover new cancer imaging biomarkersResearchers at Mass General Brigham have harnessed the technology behind foundation models, which power tools like ChatGPT, to discover new cancer imaging biomarkers that could transform how patterns are identified from radiological images. Improved identification of such patterns can greatly impact the early detection and treatment of cancer.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers discover how immune B cells hunt down cancer around the bodyScientists have discovered the key features of immune B cells that make them successful at targeting tumors—including when cancer has spread to a different part of the body.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers examine implementation of psychosocial support program for adolescents with cancerSocial isolation is a difficult experience for many people and was particularly distressing during the COVID-19 pandemic. For adolescents who are immunocompromised, physical distancing can be important in managing their risk of serious infection, but it can be an especially negative experience during some of their most formative years.
Source: medical_xpress - 🏆 101. / 51 Read more »